nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—PTGS2—ovarian follicle—ovarian cancer	0.0353	0.295	CbGeAlD
Oxaprozin—PTGS1—oviduct—ovarian cancer	0.0162	0.136	CbGeAlD
Oxaprozin—PTGS2—myometrium—ovarian cancer	0.00496	0.0415	CbGeAlD
Oxaprozin—PTGS2—embryo—ovarian cancer	0.00477	0.0399	CbGeAlD
Oxaprozin—PTGS1—epithelium—ovarian cancer	0.00407	0.0341	CbGeAlD
Oxaprozin—PTGS1—uterine cervix—ovarian cancer	0.00404	0.0338	CbGeAlD
Oxaprozin—PTGS2—epithelium—ovarian cancer	0.00389	0.0326	CbGeAlD
Oxaprozin—PTGS2—uterine cervix—ovarian cancer	0.00386	0.0323	CbGeAlD
Oxaprozin—PTGS1—endometrium—ovarian cancer	0.00365	0.0306	CbGeAlD
Oxaprozin—PTGS2—endometrium—ovarian cancer	0.00349	0.0292	CbGeAlD
Oxaprozin—PTGS1—uterus—ovarian cancer	0.00337	0.0282	CbGeAlD
Oxaprozin—CYP2C9—female reproductive system—ovarian cancer	0.00332	0.0277	CbGeAlD
Oxaprozin—PTGS2—uterus—ovarian cancer	0.00322	0.0269	CbGeAlD
Oxaprozin—PTGS1—female reproductive system—ovarian cancer	0.00303	0.0253	CbGeAlD
Oxaprozin—PTGS2—female reproductive system—ovarian cancer	0.00289	0.0242	CbGeAlD
Oxaprozin—PTGS1—female gonad—ovarian cancer	0.00275	0.0231	CbGeAlD
Oxaprozin—PTGS1—vagina—ovarian cancer	0.00274	0.0229	CbGeAlD
Oxaprozin—PTGS2—bone marrow—ovarian cancer	0.00273	0.0229	CbGeAlD
Oxaprozin—PTGS2—female gonad—ovarian cancer	0.00263	0.022	CbGeAlD
Oxaprozin—PTGS2—vagina—ovarian cancer	0.00262	0.0219	CbGeAlD
Oxaprozin—PTGS1—testis—ovarian cancer	0.00244	0.0204	CbGeAlD
Oxaprozin—PTGS1—lymph node—ovarian cancer	0.00177	0.0148	CbGeAlD
Oxaprozin—PTGS2—lymph node—ovarian cancer	0.00169	0.0142	CbGeAlD
Oxaprozin—Lethargy—Doxorubicin—ovarian cancer	0.00117	0.00133	CcSEcCtD
Oxaprozin—Leukopenia—Paclitaxel—ovarian cancer	0.00117	0.00133	CcSEcCtD
Oxaprozin—Rash—Topotecan—ovarian cancer	0.00117	0.00133	CcSEcCtD
Oxaprozin—Dermatitis—Topotecan—ovarian cancer	0.00117	0.00133	CcSEcCtD
Oxaprozin—Headache—Topotecan—ovarian cancer	0.00116	0.00132	CcSEcCtD
Oxaprozin—Palpitations—Paclitaxel—ovarian cancer	0.00116	0.00131	CcSEcCtD
Oxaprozin—Vomiting—Melphalan—ovarian cancer	0.00115	0.00131	CcSEcCtD
Oxaprozin—Loss of consciousness—Paclitaxel—ovarian cancer	0.00115	0.00131	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.00115	0.0013	CcSEcCtD
Oxaprozin—Rash—Melphalan—ovarian cancer	0.00115	0.0013	CcSEcCtD
Oxaprozin—Dermatitis—Melphalan—ovarian cancer	0.00114	0.0013	CcSEcCtD
Oxaprozin—Asthenia—Vinorelbine—ovarian cancer	0.00114	0.00129	CcSEcCtD
Oxaprozin—Arrhythmia—Docetaxel—ovarian cancer	0.00114	0.00129	CcSEcCtD
Oxaprozin—Abdominal pain upper—Epirubicin—ovarian cancer	0.00113	0.00129	CcSEcCtD
Oxaprozin—Convulsion—Paclitaxel—ovarian cancer	0.00113	0.00129	CcSEcCtD
Oxaprozin—Hypertension—Paclitaxel—ovarian cancer	0.00113	0.00128	CcSEcCtD
Oxaprozin—Alopecia—Docetaxel—ovarian cancer	0.00113	0.00128	CcSEcCtD
Oxaprozin—Pruritus—Vinorelbine—ovarian cancer	0.00112	0.00128	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00112	0.00127	CcSEcCtD
Oxaprozin—Anxiety—Paclitaxel—ovarian cancer	0.00111	0.00126	CcSEcCtD
Oxaprozin—Nausea—Topotecan—ovarian cancer	0.0011	0.00125	CcSEcCtD
Oxaprozin—Discomfort—Paclitaxel—ovarian cancer	0.0011	0.00125	CcSEcCtD
Oxaprozin—Gastritis—Epirubicin—ovarian cancer	0.0011	0.00125	CcSEcCtD
Oxaprozin—Dry mouth—Paclitaxel—ovarian cancer	0.00109	0.00124	CcSEcCtD
Oxaprozin—Diarrhoea—Vinorelbine—ovarian cancer	0.00109	0.00123	CcSEcCtD
Oxaprozin—Dysgeusia—Docetaxel—ovarian cancer	0.00109	0.00123	CcSEcCtD
Oxaprozin—Nausea—Melphalan—ovarian cancer	0.00108	0.00123	CcSEcCtD
Oxaprozin—Confusional state—Paclitaxel—ovarian cancer	0.00108	0.00122	CcSEcCtD
Oxaprozin—Asthma—Epirubicin—ovarian cancer	0.00107	0.00122	CcSEcCtD
Oxaprozin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00107	0.00121	CcSEcCtD
Oxaprozin—Oedema—Paclitaxel—ovarian cancer	0.00107	0.00121	CcSEcCtD
Oxaprozin—Eosinophilia—Epirubicin—ovarian cancer	0.00106	0.00121	CcSEcCtD
Oxaprozin—Infection—Paclitaxel—ovarian cancer	0.00106	0.0012	CcSEcCtD
Oxaprozin—Pancreatitis—Epirubicin—ovarian cancer	0.00105	0.00119	CcSEcCtD
Oxaprozin—Shock—Paclitaxel—ovarian cancer	0.00105	0.00119	CcSEcCtD
Oxaprozin—Dizziness—Vinorelbine—ovarian cancer	0.00105	0.00119	CcSEcCtD
Oxaprozin—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00105	0.00119	CcSEcCtD
Oxaprozin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00105	0.00119	CcSEcCtD
Oxaprozin—Tachycardia—Paclitaxel—ovarian cancer	0.00104	0.00118	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00103	0.00117	CcSEcCtD
Oxaprozin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00103	0.00117	CcSEcCtD
Oxaprozin—Anaemia—Docetaxel—ovarian cancer	0.00102	0.00116	CcSEcCtD
Oxaprozin—Pancytopenia—Epirubicin—ovarian cancer	0.00102	0.00116	CcSEcCtD
Oxaprozin—Anorexia—Paclitaxel—ovarian cancer	0.00102	0.00116	CcSEcCtD
Oxaprozin—Gastritis—Doxorubicin—ovarian cancer	0.00102	0.00115	CcSEcCtD
Oxaprozin—Vomiting—Vinorelbine—ovarian cancer	0.00101	0.00115	CcSEcCtD
Oxaprozin—Dysuria—Epirubicin—ovarian cancer	0.001	0.00114	CcSEcCtD
Oxaprozin—Rash—Vinorelbine—ovarian cancer	0.001	0.00114	CcSEcCtD
Oxaprozin—Dermatitis—Vinorelbine—ovarian cancer	0.001	0.00114	CcSEcCtD
Oxaprozin—Hypotension—Paclitaxel—ovarian cancer	0.000997	0.00113	CcSEcCtD
Oxaprozin—Headache—Vinorelbine—ovarian cancer	0.000994	0.00113	CcSEcCtD
Oxaprozin—Syncope—Docetaxel—ovarian cancer	0.000994	0.00113	CcSEcCtD
Oxaprozin—Asthma—Doxorubicin—ovarian cancer	0.000993	0.00113	CcSEcCtD
Oxaprozin—Leukopenia—Docetaxel—ovarian cancer	0.000992	0.00113	CcSEcCtD
Oxaprozin—Eosinophilia—Doxorubicin—ovarian cancer	0.000983	0.00112	CcSEcCtD
Oxaprozin—Palpitations—Docetaxel—ovarian cancer	0.00098	0.00111	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000979	0.00111	CcSEcCtD
Oxaprozin—Loss of consciousness—Docetaxel—ovarian cancer	0.000974	0.00111	CcSEcCtD
Oxaprozin—Pancreatitis—Doxorubicin—ovarian cancer	0.000973	0.00111	CcSEcCtD
Oxaprozin—Hyperglycaemia—Epirubicin—ovarian cancer	0.000968	0.0011	CcSEcCtD
Oxaprozin—Insomnia—Paclitaxel—ovarian cancer	0.000965	0.0011	CcSEcCtD
Oxaprozin—Pneumonia—Epirubicin—ovarian cancer	0.000962	0.00109	CcSEcCtD
Oxaprozin—Convulsion—Docetaxel—ovarian cancer	0.00096	0.00109	CcSEcCtD
Oxaprozin—Paraesthesia—Paclitaxel—ovarian cancer	0.000958	0.00109	CcSEcCtD
Oxaprozin—Hypertension—Docetaxel—ovarian cancer	0.000957	0.00109	CcSEcCtD
Oxaprozin—Drowsiness—Epirubicin—ovarian cancer	0.000957	0.00109	CcSEcCtD
Oxaprozin—Dyspnoea—Paclitaxel—ovarian cancer	0.000952	0.00108	CcSEcCtD
Oxaprozin—Somnolence—Paclitaxel—ovarian cancer	0.000949	0.00108	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000949	0.00108	CcSEcCtD
Oxaprozin—Pancytopenia—Doxorubicin—ovarian cancer	0.000943	0.00107	CcSEcCtD
Oxaprozin—Nausea—Vinorelbine—ovarian cancer	0.000943	0.00107	CcSEcCtD
Oxaprozin—Renal failure—Epirubicin—ovarian cancer	0.00094	0.00107	CcSEcCtD
Oxaprozin—Dyspepsia—Paclitaxel—ovarian cancer	0.00094	0.00107	CcSEcCtD
Oxaprozin—Jaundice—Epirubicin—ovarian cancer	0.000933	0.00106	CcSEcCtD
Oxaprozin—Stomatitis—Epirubicin—ovarian cancer	0.000933	0.00106	CcSEcCtD
Oxaprozin—Conjunctivitis—Epirubicin—ovarian cancer	0.00093	0.00106	CcSEcCtD
Oxaprozin—Dysuria—Doxorubicin—ovarian cancer	0.000928	0.00105	CcSEcCtD
Oxaprozin—Decreased appetite—Paclitaxel—ovarian cancer	0.000928	0.00105	CcSEcCtD
Oxaprozin—Dry mouth—Docetaxel—ovarian cancer	0.000923	0.00105	CcSEcCtD
Oxaprozin—Constipation—Paclitaxel—ovarian cancer	0.000913	0.00104	CcSEcCtD
Oxaprozin—Haematuria—Epirubicin—ovarian cancer	0.000912	0.00104	CcSEcCtD
Oxaprozin—Confusional state—Docetaxel—ovarian cancer	0.000912	0.00104	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000906	0.00103	CcSEcCtD
Oxaprozin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000905	0.00103	CcSEcCtD
Oxaprozin—Oedema—Docetaxel—ovarian cancer	0.000905	0.00103	CcSEcCtD
Oxaprozin—Infection—Docetaxel—ovarian cancer	0.000899	0.00102	CcSEcCtD
Oxaprozin—Sinusitis—Epirubicin—ovarian cancer	0.000898	0.00102	CcSEcCtD
Oxaprozin—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000896	0.00102	CcSEcCtD
Oxaprozin—Agranulocytosis—Epirubicin—ovarian cancer	0.000893	0.00101	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—ovarian cancer	0.00089	0.00101	CcSEcCtD
Oxaprozin—Shock—Docetaxel—ovarian cancer	0.00089	0.00101	CcSEcCtD
Oxaprozin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000886	0.00101	CcSEcCtD
Oxaprozin—Drowsiness—Doxorubicin—ovarian cancer	0.000885	0.00101	CcSEcCtD
Oxaprozin—Tachycardia—Docetaxel—ovarian cancer	0.000883	0.001	CcSEcCtD
Oxaprozin—Feeling abnormal—Paclitaxel—ovarian cancer	0.00088	0.000999	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000878	0.000997	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000873	0.000991	CcSEcCtD
Oxaprozin—Renal failure—Doxorubicin—ovarian cancer	0.00087	0.000988	CcSEcCtD
Oxaprozin—Haemoglobin—Epirubicin—ovarian cancer	0.000863	0.00098	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—ovarian cancer	0.000863	0.00098	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—ovarian cancer	0.000863	0.00098	CcSEcCtD
Oxaprozin—Anorexia—Docetaxel—ovarian cancer	0.000862	0.000979	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000861	0.000977	CcSEcCtD
Oxaprozin—Haemorrhage—Epirubicin—ovarian cancer	0.000859	0.000975	CcSEcCtD
Oxaprozin—Hepatitis—Epirubicin—ovarian cancer	0.000859	0.000975	CcSEcCtD
Oxaprozin—Urticaria—Paclitaxel—ovarian cancer	0.000848	0.000963	CcSEcCtD
Oxaprozin—Hypotension—Docetaxel—ovarian cancer	0.000845	0.00096	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—ovarian cancer	0.000844	0.000959	CcSEcCtD
Oxaprozin—Abdominal pain—Paclitaxel—ovarian cancer	0.000844	0.000958	CcSEcCtD
Oxaprozin—Body temperature increased—Paclitaxel—ovarian cancer	0.000844	0.000958	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—ovarian cancer	0.000831	0.000943	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000826	0.000938	CcSEcCtD
Oxaprozin—Insomnia—Docetaxel—ovarian cancer	0.000818	0.000929	CcSEcCtD
Oxaprozin—Paraesthesia—Docetaxel—ovarian cancer	0.000812	0.000923	CcSEcCtD
Oxaprozin—Erythema multiforme—Epirubicin—ovarian cancer	0.000812	0.000922	CcSEcCtD
Oxaprozin—Dyspnoea—Docetaxel—ovarian cancer	0.000807	0.000916	CcSEcCtD
Oxaprozin—Somnolence—Docetaxel—ovarian cancer	0.000804	0.000913	CcSEcCtD
Oxaprozin—Tinnitus—Epirubicin—ovarian cancer	0.000801	0.000909	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—ovarian cancer	0.000799	0.000907	CcSEcCtD
Oxaprozin—Dyspepsia—Docetaxel—ovarian cancer	0.000796	0.000904	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—ovarian cancer	0.000795	0.000903	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—ovarian cancer	0.000795	0.000903	CcSEcCtD
Oxaprozin—Decreased appetite—Docetaxel—ovarian cancer	0.000786	0.000893	CcSEcCtD
Oxaprozin—Constipation—Docetaxel—ovarian cancer	0.000774	0.000879	CcSEcCtD
Oxaprozin—Arrhythmia—Epirubicin—ovarian cancer	0.000767	0.000871	CcSEcCtD
Oxaprozin—Asthenia—Paclitaxel—ovarian cancer	0.000766	0.00087	CcSEcCtD
Oxaprozin—Alopecia—Epirubicin—ovarian cancer	0.000759	0.000862	CcSEcCtD
Oxaprozin—Pruritus—Paclitaxel—ovarian cancer	0.000755	0.000858	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000751	0.000853	CcSEcCtD
Oxaprozin—Feeling abnormal—Docetaxel—ovarian cancer	0.000746	0.000847	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—ovarian cancer	0.000741	0.000841	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00074	0.00084	CcSEcCtD
Oxaprozin—Flatulence—Epirubicin—ovarian cancer	0.000737	0.000837	CcSEcCtD
Oxaprozin—Tension—Epirubicin—ovarian cancer	0.000734	0.000833	CcSEcCtD
Oxaprozin—Dysgeusia—Epirubicin—ovarian cancer	0.000732	0.000832	CcSEcCtD
Oxaprozin—Diarrhoea—Paclitaxel—ovarian cancer	0.00073	0.000829	CcSEcCtD
Oxaprozin—Nervousness—Epirubicin—ovarian cancer	0.000726	0.000825	CcSEcCtD
Oxaprozin—Abdominal pain—Docetaxel—ovarian cancer	0.000715	0.000812	CcSEcCtD
Oxaprozin—Body temperature increased—Docetaxel—ovarian cancer	0.000715	0.000812	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—ovarian cancer	0.00071	0.000806	CcSEcCtD
Oxaprozin—Dizziness—Paclitaxel—ovarian cancer	0.000706	0.000802	CcSEcCtD
Oxaprozin—Vision blurred—Epirubicin—ovarian cancer	0.000705	0.0008	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—ovarian cancer	0.000702	0.000798	CcSEcCtD
Oxaprozin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000694	0.000788	CcSEcCtD
Oxaprozin—Anaemia—Epirubicin—ovarian cancer	0.000691	0.000785	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—ovarian cancer	0.000682	0.000774	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—ovarian cancer	0.000679	0.000771	CcSEcCtD
Oxaprozin—Vomiting—Paclitaxel—ovarian cancer	0.000679	0.000771	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—ovarian cancer	0.000677	0.000769	CcSEcCtD
Oxaprozin—Malaise—Epirubicin—ovarian cancer	0.000674	0.000766	CcSEcCtD
Oxaprozin—Rash—Paclitaxel—ovarian cancer	0.000673	0.000764	CcSEcCtD
Oxaprozin—Dermatitis—Paclitaxel—ovarian cancer	0.000672	0.000764	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—ovarian cancer	0.000672	0.000763	CcSEcCtD
Oxaprozin—Vertigo—Epirubicin—ovarian cancer	0.000672	0.000763	CcSEcCtD
Oxaprozin—Syncope—Epirubicin—ovarian cancer	0.000671	0.000761	CcSEcCtD
Oxaprozin—Leukopenia—Epirubicin—ovarian cancer	0.000669	0.00076	CcSEcCtD
Oxaprozin—Headache—Paclitaxel—ovarian cancer	0.000669	0.000759	CcSEcCtD
Oxaprozin—Palpitations—Epirubicin—ovarian cancer	0.000661	0.00075	CcSEcCtD
Oxaprozin—Loss of consciousness—Epirubicin—ovarian cancer	0.000657	0.000746	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—ovarian cancer	0.000652	0.00074	CcSEcCtD
Oxaprozin—Asthenia—Docetaxel—ovarian cancer	0.000649	0.000737	CcSEcCtD
Oxaprozin—Convulsion—Epirubicin—ovarian cancer	0.000648	0.000736	CcSEcCtD
Oxaprozin—Hypertension—Epirubicin—ovarian cancer	0.000646	0.000733	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000642	0.000729	CcSEcCtD
Oxaprozin—Pruritus—Docetaxel—ovarian cancer	0.00064	0.000727	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—ovarian cancer	0.000639	0.000726	CcSEcCtD
Oxaprozin—Anxiety—Epirubicin—ovarian cancer	0.000634	0.00072	CcSEcCtD
Oxaprozin—Nausea—Paclitaxel—ovarian cancer	0.000634	0.00072	CcSEcCtD
Oxaprozin—Discomfort—Epirubicin—ovarian cancer	0.000629	0.000714	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—ovarian cancer	0.000624	0.000709	CcSEcCtD
Oxaprozin—Dry mouth—Epirubicin—ovarian cancer	0.000623	0.000707	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—ovarian cancer	0.000622	0.000706	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—ovarian cancer	0.00062	0.000705	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—ovarian cancer	0.000619	0.000703	CcSEcCtD
Oxaprozin—Diarrhoea—Docetaxel—ovarian cancer	0.000619	0.000703	CcSEcCtD
Oxaprozin—Confusional state—Epirubicin—ovarian cancer	0.000615	0.000699	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—ovarian cancer	0.000611	0.000694	CcSEcCtD
Oxaprozin—Oedema—Epirubicin—ovarian cancer	0.00061	0.000693	CcSEcCtD
Oxaprozin—Anaphylactic shock—Epirubicin—ovarian cancer	0.00061	0.000693	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000608	0.000691	CcSEcCtD
Oxaprozin—Infection—Epirubicin—ovarian cancer	0.000606	0.000688	CcSEcCtD
Oxaprozin—Shock—Epirubicin—ovarian cancer	0.0006	0.000682	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—ovarian cancer	0.000599	0.000681	CcSEcCtD
Oxaprozin—Dizziness—Docetaxel—ovarian cancer	0.000598	0.000679	CcSEcCtD
Oxaprozin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000597	0.000679	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—ovarian cancer	0.000597	0.000678	CcSEcCtD
Oxaprozin—Tachycardia—Epirubicin—ovarian cancer	0.000596	0.000676	CcSEcCtD
Oxaprozin—Hyperhidrosis—Epirubicin—ovarian cancer	0.00059	0.00067	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—ovarian cancer	0.000587	0.000667	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—ovarian cancer	0.000582	0.000661	CcSEcCtD
Oxaprozin—Anorexia—Epirubicin—ovarian cancer	0.000582	0.000661	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—ovarian cancer	0.000576	0.000654	CcSEcCtD
Oxaprozin—Vomiting—Docetaxel—ovarian cancer	0.000575	0.000653	CcSEcCtD
Oxaprozin—Rash—Docetaxel—ovarian cancer	0.00057	0.000648	CcSEcCtD
Oxaprozin—Hypotension—Epirubicin—ovarian cancer	0.00057	0.000648	CcSEcCtD
Oxaprozin—Dermatitis—Docetaxel—ovarian cancer	0.00057	0.000647	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—ovarian cancer	0.000569	0.000647	CcSEcCtD
Oxaprozin—Headache—Docetaxel—ovarian cancer	0.000567	0.000644	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000565	0.000641	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—ovarian cancer	0.000565	0.000641	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—ovarian cancer	0.000561	0.000637	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—ovarian cancer	0.000555	0.000631	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000553	0.000628	CcSEcCtD
Oxaprozin—Insomnia—Epirubicin—ovarian cancer	0.000552	0.000627	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—ovarian cancer	0.000551	0.000626	CcSEcCtD
Oxaprozin—Paraesthesia—Epirubicin—ovarian cancer	0.000548	0.000622	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000546	0.00062	CcSEcCtD
Oxaprozin—Dyspnoea—Epirubicin—ovarian cancer	0.000544	0.000618	CcSEcCtD
Oxaprozin—Somnolence—Epirubicin—ovarian cancer	0.000542	0.000616	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—ovarian cancer	0.000538	0.000611	CcSEcCtD
Oxaprozin—Nausea—Docetaxel—ovarian cancer	0.000537	0.00061	CcSEcCtD
Oxaprozin—Dyspepsia—Epirubicin—ovarian cancer	0.000537	0.00061	CcSEcCtD
Oxaprozin—Decreased appetite—Epirubicin—ovarian cancer	0.00053	0.000602	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—ovarian cancer	0.000528	0.000599	CcSEcCtD
Oxaprozin—Constipation—Epirubicin—ovarian cancer	0.000522	0.000593	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—ovarian cancer	0.000511	0.00058	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—ovarian cancer	0.000507	0.000576	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—ovarian cancer	0.000503	0.000572	CcSEcCtD
Oxaprozin—Feeling abnormal—Epirubicin—ovarian cancer	0.000503	0.000571	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—ovarian cancer	0.000502	0.00057	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000499	0.000567	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—ovarian cancer	0.000497	0.000564	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—ovarian cancer	0.000491	0.000557	CcSEcCtD
Oxaprozin—Urticaria—Epirubicin—ovarian cancer	0.000485	0.000551	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—ovarian cancer	0.000483	0.000548	CcSEcCtD
Oxaprozin—Abdominal pain—Epirubicin—ovarian cancer	0.000482	0.000548	CcSEcCtD
Oxaprozin—Body temperature increased—Epirubicin—ovarian cancer	0.000482	0.000548	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000465	0.000528	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000462	0.000524	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—ovarian cancer	0.000449	0.000509	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—ovarian cancer	0.000446	0.000507	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—ovarian cancer	0.000446	0.000507	CcSEcCtD
Oxaprozin—Asthenia—Epirubicin—ovarian cancer	0.000438	0.000497	CcSEcCtD
Oxaprozin—Pruritus—Epirubicin—ovarian cancer	0.000432	0.00049	CcSEcCtD
Oxaprozin—Diarrhoea—Epirubicin—ovarian cancer	0.000418	0.000474	CcSEcCtD
Oxaprozin—Asthenia—Doxorubicin—ovarian cancer	0.000405	0.00046	CcSEcCtD
Oxaprozin—Dizziness—Epirubicin—ovarian cancer	0.000404	0.000458	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—ovarian cancer	0.000399	0.000454	CcSEcCtD
Oxaprozin—Vomiting—Epirubicin—ovarian cancer	0.000388	0.000441	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—ovarian cancer	0.000386	0.000439	CcSEcCtD
Oxaprozin—Rash—Epirubicin—ovarian cancer	0.000385	0.000437	CcSEcCtD
Oxaprozin—Dermatitis—Epirubicin—ovarian cancer	0.000384	0.000437	CcSEcCtD
Oxaprozin—Headache—Epirubicin—ovarian cancer	0.000382	0.000434	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—ovarian cancer	0.000373	0.000424	CcSEcCtD
Oxaprozin—Nausea—Epirubicin—ovarian cancer	0.000362	0.000412	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—ovarian cancer	0.000359	0.000408	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—ovarian cancer	0.000356	0.000404	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—ovarian cancer	0.000356	0.000404	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—ovarian cancer	0.000354	0.000402	CcSEcCtD
Oxaprozin—Nausea—Doxorubicin—ovarian cancer	0.000335	0.000381	CcSEcCtD
